Numinus Launches Psychedelic-Assisted Therapy For Chronic & Serious Medical Illness

Numinus Wellness Inc. (Numinus), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, has launched its Ketamine for Chronic and Serious Medical Illness Program. This new program will be introduced first in Numinus' clinics in Utah, British Columbia, and Quebec. The Company intends to expand the program to other clinics in later months.

Numinus' program will offer ketamine-assisted therapy alongside additional community support, and has a targeted focus on improving consumers' physical, emotional, mental, and spiritual suffering caused by their illness. Care is provided by health care professionals who are specifically trained in . . .